CUSIP: 576810105
Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,675,710
-
Share change
-
+3,008,082
-
Total reported value
-
$67,359,057
-
Price per share
-
$2.27
-
Number of holders
-
61
-
Value change
-
+$10,094,775
-
Number of buys
-
41
-
Number of sells
-
10
Quarterly Holders Quick Answers
What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2020
-
Previous quarter:
Q3 2019
Recent filing periods for CUSIP 576810105:
Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q4 2019
As of 31 Dec 2019,
MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,675,710 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Raymond James Financial Services Advisors, Inc., ROYAL BANK OF CANADA, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and STALEY CAPITAL ADVISERS INC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.